Prime Medicine prices $125M stock offering at $3.50/share
AI Summary
Prime Medicine priced a $125 million stock offering at $3.50 per share. The transaction will raise capital for the biotechnology company through an equity issuance.
Prime Medicine priced a $125 million stock offering at $3.50 per share. The transaction will raise capital for the biotechnology company through an equity issuance.
The Sydney Morning Herald —
Warsaw Business Journal —
The Verge —
MarketWatch —
Investing.com —
Vanguard Nigeria —